Calpain and synaptic function

被引:132
作者
Wu, Hai-Van
Lynch, David R. [1 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
关键词
calpain; calcium; NNMA receptor; proteolysis; synapse;
D O I
10.1385/MN:33:3:215
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Proteolysis by calpain is a unique posttranslational modification that can change integrity, localization, and activity of endogenous proteins. Two ubiquitous calpains, mu-calpain and m-calpain, are highly expressed in the central nervous system, and calpain substrates such as membrane receptors, postsynaptic density proteins, kinases, and phosphatases are localized to the synaptic compartments of neurons. By selective cleavage of synaptically localized molecules, calpains may play pivotal roles in the regulation of synaptic processes not only in physiological states but also during various pathological conditions. Activation of calpains during sustained synaptic activity is crucial for Ca2+-dependent neuronal functions, such as neurotransmitter release, synaptic plasticity, vesicular trafficking, and structural stabilization. Overactivation of calpain following dysregulation of Ca2+ homeostasis can lead to neuronal damage in response to events such as epilepsy, stroke, and brain trauma. Calpain may also provide a neuroprotective effect from axotomy and some forms of glutamate receptor overactivation. This article focuses on recent findings on the role of calpain-mediated proteolytic processes in potentially regulating synaptic substrates in physiological and pathophysiological events in the nervous system.
引用
收藏
页码:215 / 236
页数:22
相关论文
共 187 条
[1]   Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD [J].
Ahmadian, G ;
Ju, W ;
Liu, LD ;
Wyszynski, M ;
Lee, SH ;
Dunah, AW ;
Taghibiglou, C ;
Wang, YS ;
Lu, J ;
Wong, TP ;
Sheng, M ;
Wang, YT .
EMBO JOURNAL, 2004, 23 (05) :1040-1050
[2]  
Araújo IM, 2005, NEUROREPORT, V16, P393
[3]   Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons [J].
Araújo, IM ;
Verdasca, MJ ;
Leal, EC ;
Bahr, BA ;
Ambrósio, AF ;
Carvalho, AP ;
Carvalho, CM .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (06) :1322-1331
[4]   Neuronal nitric oxide synthase proteolysis limits the involvement of nitric oxide in kainate-induced neurotoxicity in hippocampal neurons [J].
Araújo, IM ;
Ambrósio, AF ;
Leal, EC ;
Santos, PF ;
Carvalho, AP ;
Carvalho, CM .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (03) :791-800
[5]   Disruption of the murine calpain small subunit gene, Capn4:: Calpain is essential for embryonic development but not for cell growth and division [J].
Arthur, JSC ;
Elce, JS ;
Hegadorn, C ;
Williams, K ;
Greer, PA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4474-4481
[6]   Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles [J].
Augustinack, JC ;
Sanders, JL ;
Tsai, LH ;
Hyman, BT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (06) :557-564
[7]   Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity [J].
Bano, D ;
Young, KW ;
Guerin, CJ ;
LeFeuvre, R ;
Rothwell, NJ ;
Naldini, L ;
Rizzuto, R ;
Carafoli, E ;
Nicotera, P .
CELL, 2005, 120 (02) :275-285
[8]   POSTISCHEMIC ADMINISTRATION OF AK275, A CALPAIN INHIBITOR, PROVIDES SUBSTANTIAL PROTECTION AGAINST FOCAL ISCHEMIC BRAIN-DAMAGE [J].
BARTUS, RT ;
BAKER, KL ;
HEISER, AD ;
SAWYER, SD ;
DEAN, RL ;
ELLIOTT, PJ ;
STRAUB, JA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (04) :537-544
[9]   CALPAIN INHIBITOR AK295 PROTECTS NEURONS FROM FOCAL BRAIN ISCHEMIA - EFFECTS OF POSTOCCLUSION INTRAARTERIAL ADMINISTRATION [J].
BARTUS, RT ;
HAYWARD, NJ ;
ELLIOTT, PJ ;
SAWYER, SD ;
BAKER, KL ;
DEAN, RL ;
AKIYAMA, A ;
STRAUB, JA ;
HARBESON, SL ;
LI, Z ;
POWERS, J .
STROKE, 1994, 25 (11) :2265-2270
[10]   CALPAIN AS A NOVEL TARGET FOR TREATING ACUTE NEURODEGENERATIVE DISORDERS [J].
BARTUS, RT ;
ELLIOTT, PJ ;
HAYWARD, NJ ;
DEAN, RL ;
HARBESON, S ;
STRAUB, JA ;
LI, Z ;
POWERS, JC .
NEUROLOGICAL RESEARCH, 1995, 17 (04) :249-258